{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hereditary-thrombocytopenia-and-hematological-cancer-predisposition-syndrome-associated-with-runx1","columns":[{"gene":"","key":"population-a34962caafbf47af9a35","label":"Platelet disorder, familial, with associated myeloid malignancy","mondoId":"MONDO:0100083","onsetQualifier":null,"originColumnKey":"MONDO:0100083/OMIM:601399","originalViews":[{"key":"MONDO:0100083/OMIM:601399","label":"Platelet disorder, familial, with associated myeloid malignancy","scopeLabel":"OMIM:601399","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["18425d1764248b397ab5572510a0525a8f6d45a0a58b21646cab54c6bbad42ef","215a0d33578593e217048fd8fd4ec372e921f533d866eb1723beca09defd5581","2aaf60be7da8ed1fd8fa318f1086058c8872018c45d56cb683f7ab6fc51357f4","2d19a875f0a4ccb147a3acf79bbed45e0151a9bdf64ef8bcc4df17d66293115e","342948a6781482c00f172b3cde241c3dc44db065b2b296af2e5b41a503eda4e0","403148f9636f18f88ad8149d42366fd49d9e16b78894851366842dd759908f9f","4c4959926c4a9dd091a71819d87df2c99251b21a5e50ae03a4618fbd6a50db68","6adee358e0647f8215fe0d3e1cb373f0760e6565341fd04305cbd5c1aec09114","742dd1996f16ec25886e3323194139410575f7a639bb777f6955ebb29b877e22","7bf3b864a1d1307fee545b682405abe9d0f57a20316812155c7b9b2eac33981a","7e39da02d1923bcc230023c981ba74a2b9e21164336853720ed322950c44fcbc","8a3baaf64ac20d2fecde7b86ad1fb9660792eb8ad368aaf5db25a164007bec02","918ff74ed7438d789b40754c702a2c604214ef90f30e08e7625916033509bc0b","944d92e43f60364a4d9c227f423ff70d2fb5077dfd3c855c396a33324ac3926e","ad7fe7aa8a48c3d2a995c135630b1603bb7a6749fbcb1b12b12064249947ee46","aec3a285f8007f657b322eecbe1a1b4f2882cab0c75b9fa581bc293b2ff695b4","c2681b2d02873a9a7a6f56caa64e032dbb884d300d1b89d810c2784a168dade2","c468ba771a2fec520e8a551a63d33f007290329e439429405351b147ed1599b6","feb46384ab0bc81afc64c225eff82767e18d3c5ab5e89b37031c155993af6553"],"recordQualifiers":{},"scopeLabel":"OMIM:601399","sourceIds":["OMIM:601399"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-a34962caafbf47af9a35"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012527","HP:0012529","HP:0012524","HP:0004845","HP:0004808","HP:0000978","HP:0031364"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":13,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":19,"sourceGroups":{"omim":6,"published":13}},"features":[{"hpoId":"HP:0012527","label":"Abnormal alpha granule content","primary":true},{"hpoId":"HP:0012529","label":"Abnormal dense granule content","primary":true},{"hpoId":"HP:0012524","label":"Abnormal platelet shape","primary":true},{"hpoId":"HP:0004845","label":"Acute monocytic leukemia","primary":true},{"hpoId":"HP:0004808","label":"Acute myeloid leukemia","primary":true},{"hpoId":"HP:0000978","label":"Bruising susceptibility","primary":true},{"hpoId":"HP:0031364","label":"Ecchymosis","primary":true},{"hpoId":"HP:0000421","label":"Epistaxis","primary":false},{"hpoId":"HP:0004866","label":"Impaired ADP-induced platelet aggregation","primary":false},{"hpoId":"HP:0011870","label":"Impaired arachidonic acid-induced platelet aggregation","primary":false},{"hpoId":"HP:0008320","label":"Impaired collagen-induced platelet aggregation","primary":false},{"hpoId":"HP:0003540","label":"Impaired platelet aggregation","primary":false},{"hpoId":"HP:0002665","label":"Lymphoma","primary":false},{"hpoId":"HP:0002863","label":"Myelodysplasia","primary":false},{"hpoId":"HP:0003006","label":"Neuroblastoma","primary":false},{"hpoId":"HP:0000967","label":"Petechiae","primary":false},{"hpoId":"HP:0003010","label":"Prolonged bleeding time","primary":false},{"hpoId":"HP:0000979","label":"Purpura","primary":false},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false}],"ledeHtml":"Familial platelet disorder with associated myeloid malignancy (FPDMM) is a condition that can cause prolonged bleeding and easy bruising. It may also cause an increased risk of developing cancer of the blood. People with this disorder often have thrombocytopenia which can lead to abnormal bleeding. Thrombocytopenia is a low number of platelet cells. The most common type of blood cancer associated with this condition is acute myelogenous leukemia. But, other types of blood cancers can also occur. These other cancers include myelodysplastic syndrome, T- and B-cell lymphoblastic leukemias, and lymphomas. Some people also experience skin-related symptoms like eczema or psoriasis. FPDMM is caused by mutations in the RUNX1 gene. It is inherited in an autosomal dominant pattern. This means a single copy of the mutated gene is sufficient to cause the disorder.","mondoId":"MONDO:0100083","node":{"canonicalSlug":"hereditary-thrombocytopenia-and-hematological-cancer-predisposition-syndrome-associated-with-runx1","comparisons":[{"documentSha256":"46fa1652ac974f0af68b758649c028769b849a51fe0a44f01f3de58fe68cae5f","key":"legacy-hereditary-thrombocytopenia-and-hematologic-cancer-predisposition","kind":"legacy","label":"hereditary thrombocytopenia and hematologic cancer predisposition syndrome","memberIds":["MONDO:0011071","MONDO:0014536","MONDO:0100083"],"mondoId":"MONDO:0011071","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hereditary-thrombocytopenia-and-hematologic-cancer-predisposition.46fa1652ac974f0af68b758649c028769b849a51fe0a44f01f3de58fe68cae5f.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1","originalSourceId":"OMIM:601399","paragraphs":["Familial platelet disorder with associated myeloid malignancy (FPDMM) is a condition that can cause prolonged bleeding and easy bruising. It may also cause an increased risk of developing cancer of the blood. People with this disorder often have thrombocytopenia which can lead to abnormal bleeding. Thrombocytopenia is a low number of platelet cells. The most common type of blood cancer associated with this condition is acute myelogenous leukemia. But, other types of blood cancers can also occur. These other cancers include myelodysplastic syndrome, T- and B-cell lymphoblastic leukemias, and lymphomas. Some people also experience skin-related symptoms like eczema or psoriasis. FPDMM is caused by mutations in the RUNX1 gene. It is inherited in an autosomal dominant pattern. This means a single copy of the mutated gene is sufficient to cause the disorder."],"rawAttribution":"MONDO:0100083","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:57Z","upstream":"PlainLanguagePilotV2-Jan24","url":"https://rarediseases.info.nih.gov/diseases/15329"},"ownColumnKeys":["population-a34962caafbf47af9a35"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary thrombocytopenia and hematologic cancer predisposition syndrome","mondoId":"MONDO:0011071","slug":"hereditary-thrombocytopenia-and-hematologic-cancer-predisposition"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"count","key":"18425d1764248b397ab5572510a0525a8f6d45a0a58b21646cab54c6bbad42ef","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000967","is_excluded":false,"label":"Petechiae","onset_id":null,"reference":"PMID:18478040","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"215a0d33578593e217048fd8fd4ec372e921f533d866eb1723beca09defd5581","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"14/14","hpo_id":"HP:0012529","is_excluded":false,"label":"Abnormal dense granule content","onset_id":null,"reference":"PMID:11830488","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2aaf60be7da8ed1fd8fa318f1086058c8872018c45d56cb683f7ab6fc51357f4","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0004845","is_excluded":false,"label":"Acute monocytic leukemia","onset_id":null,"reference":"PMID:18478040","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"2d19a875f0a4ccb147a3acf79bbed45e0151a9bdf64ef8bcc4df17d66293115e","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0012527","is_excluded":false,"label":"Abnormal alpha granule content","onset_id":null,"reference":"PMID:11830488","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"342948a6781482c00f172b3cde241c3dc44db065b2b296af2e5b41a503eda4e0","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002863","is_excluded":false,"label":"Myelodysplasia","onset_id":null,"reference":"OMIM:601399","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"403148f9636f18f88ad8149d42366fd49d9e16b78894851366842dd759908f9f","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"14/14","hpo_id":"HP:0003540","is_excluded":false,"label":"Impaired platelet aggregation","onset_id":null,"reference":"PMID:11830488","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"4c4959926c4a9dd091a71819d87df2c99251b21a5e50ae03a4618fbd6a50db68","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000978","is_excluded":false,"label":"Bruising susceptibility","onset_id":null,"reference":"OMIM:601399","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"6adee358e0647f8215fe0d3e1cb373f0760e6565341fd04305cbd5c1aec09114","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0012524","is_excluded":true,"label":"Abnormal platelet shape","onset_id":null,"reference":"PMID:18478040","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"742dd1996f16ec25886e3323194139410575f7a639bb777f6955ebb29b877e22","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002665","is_excluded":false,"label":"Lymphoma","onset_id":null,"reference":"OMIM:601399","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"7bf3b864a1d1307fee545b682405abe9d0f57a20316812155c7b9b2eac33981a","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"TAS","frequency_raw":"1/1","hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"OMIM:601399","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7e39da02d1923bcc230023c981ba74a2b9e21164336853720ed322950c44fcbc","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000421","is_excluded":false,"label":"Epistaxis","onset_id":null,"reference":"OMIM:601399","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"8a3baaf64ac20d2fecde7b86ad1fb9660792eb8ad368aaf5db25a164007bec02","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000979","is_excluded":false,"label":"Purpura","onset_id":null,"reference":"PMID:18478040","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"918ff74ed7438d789b40754c702a2c604214ef90f30e08e7625916033509bc0b","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0031364","is_excluded":false,"label":"Ecchymosis","onset_id":null,"reference":"PMID:18478040","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"944d92e43f60364a4d9c227f423ff70d2fb5077dfd3c855c396a33324ac3926e","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0008320","is_excluded":false,"label":"Impaired collagen-induced platelet aggregation","onset_id":null,"reference":"PMID:18478040","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ad7fe7aa8a48c3d2a995c135630b1603bb7a6749fbcb1b12b12064249947ee46","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0004866","is_excluded":false,"label":"Impaired ADP-induced platelet aggregation","onset_id":null,"reference":"PMID:18478040","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"aec3a285f8007f657b322eecbe1a1b4f2882cab0c75b9fa581bc293b2ff695b4","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"3/14","hpo_id":"HP:0004808","is_excluded":false,"label":"Acute myeloid leukemia","onset_id":null,"reference":"PMID:11830488","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c2681b2d02873a9a7a6f56caa64e032dbb884d300d1b89d810c2784a168dade2","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"14/14","hpo_id":"HP:0003010","is_excluded":false,"label":"Prolonged bleeding time","onset_id":null,"reference":"PMID:11830488","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c468ba771a2fec520e8a551a63d33f007290329e439429405351b147ed1599b6","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003006","is_excluded":false,"label":"Neuroblastoma","onset_id":null,"reference":"OMIM:601399","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"feb46384ab0bc81afc64c225eff82767e18d3c5ab5e89b37031c155993af6553","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601399","disease_name":"Platelet disorder, familial, with associated myeloid malignancy","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0011870","is_excluded":false,"label":"Impaired arachidonic acid-induced platelet aggregation","onset_id":null,"reference":"PMID:18478040","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/15329\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100083\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>PlainLanguagePilotV2-Jan24</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Familial platelet disorder with associated myeloid malignancy (FPDMM) is a condition that can cause prolonged bleeding and easy bruising. It may also cause an increased risk of developing cancer of the blood. People with this disorder often have thrombocytopenia which can lead to abnormal bleeding. Thrombocytopenia is a low number of platelet cells. The most common type of blood cancer associated with this condition is acute myelogenous leukemia. But, other types of blood cancers can also occur. These other cancers include myelodysplastic syndrome, T- and B-cell lymphoblastic leukemias, and lymphomas. Some people also experience skin-related symptoms like eczema or psoriasis. FPDMM is caused by mutations in the RUNX1 gene. It is inherited in an autosomal dominant pattern. This means a single copy of the mutated gene is sufficient to cause the disorder.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/15329\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"hereditary-thrombocytopenia-and-hematological-cancer-predisposition-syndrome-associated-with-runx1","sourceDocuments":[{"name":"GARD: Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1","reviewed":null,"source_release":"2026-10-25T03:41:57Z","url":"https://rarediseases.info.nih.gov/diseases/15329"},{"name":"MONDO: hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0100083"}],"sourceNote":"","synonyms":["asprin-like platelet disorder","Familial Platelet Disorder with Associated Myeloid Malignancy","familial platelet disorder with associated myeloid malignancy","familial platelet syndrome with predisposition to acute myelogenous leukaemia","familial platelet syndrome with predisposition to acute myelogenous leukemia","familial thrombocytopenia with propensity to acute myelogenous leukaemia","familial thrombocytopenia with propensity to acute myelogenous leukemia","FPD/AML syndrome","FPDMM","FPS/AML syndrome","platelet disorder, aspirin-like","platelet disorder, familial, with associated myeloid malignancy","RUNX1-related hereditary thrombocytopenia and hematological cancer predisposition syndrome","thrombocytopenia, familial, with propensity to acute myelogenous leukaemia","thrombocytopenia, familial, with propensity to acute myelogenous leukemia"],"takeawayHtml":"","title":"hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1"},"schemaVersion":1}
